Mounjaro and Utrogestan: how they interact and what to do about it

You take Utrogestan every night — and then Mounjaro enters the picture

Utrogestan tends to live in medicine routines quietly: one capsule at bedtime, often tucked in a bedside drawer, the kind of habit you barely think about after the first few weeks. Then a prescriber suggests tirzepatide for weight management, and that quiet routine suddenly needs a second look.

Mounjaro works partly by slowing the rate at which food leaves the stomach. That is central to how it reduces appetite and lowers blood sugar, but it is also the mechanism that can interfere with other medicines taken by mouth. When gastric emptying slows, the window in which an oral capsule passes through the stomach and reaches the small intestine (where absorption mostly happens) changes. For some medicines, this matters very little. For others, particularly those with a narrow therapeutic window or variable bioavailability, it can mean less of the medicine reaches your bloodstream, or it arrives later than your body expects.

Utrogestan (micronised progesterone) is already a medicine whose absorption varies between individuals; food, timing and the formulation all influence how much reaches circulation. Slowing gastric emptying on top of that could reduce absorption further, though the precise degree of any effect will vary from person to person and depends on factors like dose, timing relative to food, and how far into titration you are with tirzepatide. The NHS patient information for tirzepatide notes the gastric-emptying effect and the relevance to other oral medicines.

What the guidance recommends for women on tirzepatide and oral hormonal medicines

The most specific UK guidance on this comes from NHS England. Their weight management injections resource advises that women on tirzepatide who also take HRT should consider using a transdermal form (a patch, gel or spray) rather than an oral preparation, because transdermal routes bypass the gut entirely and so sidestep the gastric-emptying question.

Utrogestan is used in two main clinical contexts: as part of HRT in perimenopause and menopause (to protect the uterine lining in women who still have a uterus and are taking oestrogen), and as luteal-phase support in fertility treatment. The transdermal alternative is more straightforward in the HRT setting, where a progestogen patch or combined preparation may achieve the same clinical goal. In fertility or IVF contexts, options are narrower and the clinical team managing your cycle will need to advise.

For anyone thinking about the broader hormonal picture while on tirzepatide, our page on Mounjaro and progesterone covers the mechanism in more detail, and there is a separate discussion of how tirzepatide sits alongside oestrogen levels that may be useful context.

The key point in the guidance is a practical one: oral contraceptives also fall into this category. The MHRA advises that women using the combined oral contraceptive pill should add a barrier method for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, because reliability of absorption may be reduced. If you take the progesterone-only pill alongside tirzepatide, that page gives specific information on what the guidance says. Women using desogestrel in particular may find our page on Mounjaro and desogestrel useful, as it covers how that specific progestogen interacts with tirzepatide's effect on gastric emptying.

Having the conversation with your prescribing team

The practical question most people arrive at is: do I need to switch my Utrogestan? The honest answer is that it depends on why you are taking it. For HRT, switching to a transdermal progestogen is a conversation worth having with your GP or menopause specialist before starting tirzepatide, or as soon as the two overlap. For luteal support in fertility treatment, the team managing your cycle will guide you, that is not a decision to make unilaterally.

There is also a timing argument some clinicians suggest in general terms: taking oral medicines that are sensitive to gastric emptying well before the period of peak tirzepatide effect. But Utrogestan is typically taken at bedtime for tolerability reasons, and shifting that timing is not straightforward. Any change should be agreed with the clinician who prescribed it.

If you are thinking about starting Mounjaro and want to understand how your current medicines fit in, the process at our free consultation includes a structured medication review by a GPhC-registered Independent Prescriber. Your answers are read by a real clinician the same day, not processed by an algorithm. For context on how the service works more broadly, our about us page explains the clinical model, and you can read about tirzepatide as a medicine in its own right.

On cost, Mounjaro pricing in the UK has changed considerably since Eli Lilly revised its list price in September 2025. Understanding what a legitimate private prescription includes (consultation, clinical review, dispensing, delivery) matters when you are comparing services. Worth checking before you commit to a provider.